
Our Research
Our Story
Rasayana is harnessing the potential of Gut-Organ Axis biology and novel gut-targeted shelved assets to deliver life-saving drugs to patients as fast as possible.

RSY-248
Our lead asset is a first-in-class, gut-restricted oral biologic

Mission
To discover and deliver transformative medicines for patients as quickly as possible, by targeting the gut and the bidirectional gut-organ biology with gut-targeted molecules.